CRISPR Interference Strategies for Studies in Essential Gene Function and Live Cell Fluorescent Imaging of DNA Elements in Escherichia Coli

Total Page:16

File Type:pdf, Size:1020Kb

CRISPR Interference Strategies for Studies in Essential Gene Function and Live Cell Fluorescent Imaging of DNA Elements in Escherichia Coli Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2020 CRISPR interference strategies for studies in essential gene function and live cell fluorescent imaging of DNA elements in Escherichia coli Nicholas John Backes Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Recommended Citation Backes, Nicholas John, "CRISPR interference strategies for studies in essential gene function and live cell fluorescent imaging of DNA elements in Escherichia coli" (2020). Graduate Theses and Dissertations. 18089. https://lib.dr.iastate.edu/etd/18089 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. CRISPR interference strategies for studies in essential gene function and live cell fluorescent imaging of DNA elements in Escherichia coli by Nicholas Backes A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Microbiology Program of Study Committee: Gregory Phillips, Major Professor Jinoh Kim Thomas Mansell Dipali Sashital Stephan Schmitz-Esser The student author, whose presentation of the scholarship herein was approved by the program of study committee, is solely responsible for the content of this dissertation. The Graduate College will ensure this dissertation is globally accessible and will not permit alterations after a degree is conferred. Iowa State University Ames, Iowa 2020 Copyright © Nicholas Backes, 2020. All rights reserved. ii TABLE OF CONTENTS Page LIST OF FIGURES ....................................................................................................................... vi LIST OF TABLES ....................................................................................................................... viii ACKNOWLEDGMENTS ............................................................................................................. ix ABSTRACT ................................................................................................................................... xi CHAPTER 1. GENERAL INTRODUCTION ................................................................................1 Motivation ................................................................................................................................. 1 Thesis Objectives ....................................................................................................................... 4 Thesis Organization ................................................................................................................... 4 CHAPTER 2. REPURPOSING CRISPR-CAS SYSTEMS AS GENETIC TOOLS IN ENTEROBACTERIACEAE ...........................................................................................................6 Abstract ...................................................................................................................................... 6 Introduction ............................................................................................................................... 6 The Basics of CRISPR-Cas ....................................................................................................... 9 CRISPR-Cas Tools for Bacteria .............................................................................................. 13 CRISPR-Cas Genome Editing ................................................................................................. 14 Alternative Bacterial Genome Editing Strategies Using CRISPR-Cas .............................. 22 CRISPR Modulation of Gene Expression ............................................................................... 25 Programmable Gene Repression by CRISPRi ................................................................... 25 Synthetic CRISPR Arrays for Multi-gene Targeting ......................................................... 27 Bacterial Cell Processes ..................................................................................................... 29 Bacterial Pathogens ............................................................................................................ 30 Synthetic Biology ............................................................................................................... 31 Metabolic Engineering ....................................................................................................... 32 Programmable Gene Activation by CRISPRa.................................................................... 32 Genetic Screens .................................................................................................................. 35 Expanding CRISPR-Cas Systems ........................................................................................... 37 Designing CRISPRi Experiments ............................................................................................ 38 Guide RNA Design ............................................................................................................ 39 Guide RNA Expression ...................................................................................................... 40 Cas9 Effector Expression ................................................................................................... 40 Location, Location, Location ............................................................................................. 41 System Selection ................................................................................................................ 41 Additional Applications of CRISPR-Cas Systems .................................................................. 42 Plasmid Curing ................................................................................................................... 42 CRISPR-based “Magic Bullets” ......................................................................................... 43 CRISPR-based Memory Devices ....................................................................................... 46 CRISPR-based Fluorescent Imaging .................................................................................. 46 In Vitro CRISPR-based Applications ................................................................................. 48 iii RNA Targeting ................................................................................................................... 49 Conclusions ............................................................................................................................. 49 Acknowledgments ................................................................................................................... 51 References ............................................................................................................................... 51 CHAPTER 3. A MODULAR CRISPR INTERFERENCE GENETIC TOOLKIT FOR CONDITIONAL GENE REPRESSION IN ESCHERICHIA COLI ............................................68 Abstract .................................................................................................................................... 68 Introduction ............................................................................................................................. 69 Materials and Methods ............................................................................................................ 71 Strains and Materials .......................................................................................................... 71 Genetic Constructions ........................................................................................................ 76 dCas9 Vector Integration.................................................................................................... 77 Targeted Repression of lac Operon Genes and β-Galactosidase Assays ........................... 78 Antibiotic Disc-diffusion Assays ....................................................................................... 79 Gene Essentiality Growth Curve Assays............................................................................ 79 Fluorescent Microscopy of Sec Substrates during CRISPRi Repression........................... 79 Translocation Pathway Depletion Assays .......................................................................... 80 Combinatorial CRISPRi Targeting of the lac Operon and Essential Gene metG .............. 80 Results ..................................................................................................................................... 81 Efficient Protocol for Integration of dCas9 ........................................................................ 81 Repression of the lac Operon ............................................................................................. 82 CRISPRi-mediated Antibiotic Sensitivity .......................................................................... 83 Essential Gene Repression with CRISPRi ......................................................................... 84 Characterizing Translocation-pathway Determinants of Membrane Proteins Using CRISPRi ............................................................................................................................
Recommended publications
  • A CRISPR Activation and Interference Toolkit for Industrial Saccharomyces Cerevisiae Strain KE6‑12 Elena Cámara, Ibai Lenitz & Yvonne Nygård*
    www.nature.com/scientificreports OPEN A CRISPR activation and interference toolkit for industrial Saccharomyces cerevisiae strain KE6‑12 Elena Cámara, Ibai Lenitz & Yvonne Nygård* Recent advances in CRISPR/Cas9 based genome editing have considerably advanced genetic engineering of industrial yeast strains. In this study, we report the construction and characterization of a toolkit for CRISPR activation and interference (CRISPRa/i) for a polyploid industrial yeast strain. In the CRISPRa/i plasmids that are available in high and low copy variants, dCas9 is expressed alone, or as a fusion with an activation or repression domain; VP64, VPR or Mxi1. The sgRNA is introduced to the CRISPRa/i plasmids from a double stranded oligonucleotide by in vivo homology‑directed repair, allowing rapid transcriptional modulation of new target genes without cloning. The CRISPRa/i toolkit was characterized by alteration of expression of fuorescent protein‑encoding genes under two diferent promoters allowing expression alterations up to ~ 2.5‑fold. Furthermore, we demonstrated the usability of the CRISPRa/i toolkit by improving the tolerance towards wheat straw hydrolysate of our industrial production strain. We anticipate that our CRISPRa/i toolkit can be widely used to assess novel targets for strain improvement and thus accelerate the design‑build‑test cycle for developing various industrial production strains. Te yeast Saccharomyces cerevisiae is one of the most commonly used microorganisms for industrial applications ranging from wine and beer fermentations to the production of biofuels and high-value metabolites1,2. How- ever, some of the current production processes are compromised by low yields and productivities, thus further optimization is required3.
    [Show full text]
  • Quantitative CRISPR Interference Screens in Yeast Identify Chemical-Genetic Interactions and New Rules for Guide RNA Design Justin D
    Smith et al. Genome Biology (2016) 17:45 DOI 10.1186/s13059-016-0900-9 RESEARCH Open Access Quantitative CRISPR interference screens in yeast identify chemical-genetic interactions and new rules for guide RNA design Justin D. Smith1,2, Sundari Suresh1, Ulrich Schlecht1, Manhong Wu3, Omar Wagih4, Gary Peltz3, Ronald W. Davis1, Lars M. Steinmetz1,2,5, Leopold Parts2,5,6* and Robert P. St.Onge1* Abstract Background: Genome-scale CRISPR interference (CRISPRi) has been used in human cell lines; however, the features of effective guide RNAs (gRNAs) in different organisms have not been well characterized. Here, we define rules that determine gRNA effectiveness for transcriptional repression in Saccharomyces cerevisiae. Results: We create an inducible single plasmid CRISPRi system for gene repression in yeast, and use it to analyze fitness effects of gRNAs under 18 small molecule treatments. Our approach correctly identifies previously described chemical-genetic interactions, as well as a new mechanism of suppressing fluconazole toxicity by repression of the ERG25 gene. Assessment of multiple target loci across treatments using gRNA libraries allows us to determine generalizable features associated with gRNA efficacy. Guides that target regions with low nucleosome occupancy and high chromatin accessibility are clearly more effective. We also find that the best region to target gRNAs is between the transcription start site (TSS) and 200 bp upstream of the TSS. Finally, unlike nuclease-proficient Cas9 in human cells, the specificity of truncated gRNAs (18 nt of complementarity to the target) is not clearly superior to full-length gRNAs (20 nt of complementarity), as truncated gRNAs are generally less potent against both mismatched and perfectly matched targets.
    [Show full text]
  • Prevalence of Antibiotic-Resistant, Toxic Metal-Tolerant and Biofilm- Forming Bacteria in Hospital Surroundings
    Vol: 35(3), Article ID: e2020018, 19 pages https://doi.org/10.5620/eaht.2020018 eISSN: 2671-9525 1 Original Article 2 Prevalence of antibiotic-resistant, toxic metal-tolerant and biofilm- 3 forming bacteria in hospital surroundings 4 Soumitra Nath1,2,3,* , Ahana Sinha1, Y. Suchitra Singha1, Ankita Dey1, Nilakshi Bhattacharjee1 and Bibhas Deb1,2,3 5 6 1 Department of Biotechnology, Gurucharan College, Silchar, Assam, India 7 2 Bioinformatics Centre, Gurucharan College, Silchar, Assam, India 8 3 Institutional Biotech Hub, Gurucharan College, Silchar, Assam, India 9 *Correspondence: [email protected] 10 11 Received: April 19, 2020 Accepted: August 31, 2020 Abstract The emergence and rapid spread of antibiotic-resistant bacteria due to unethical and non-scientific disposal of hospital wastes and clinical by-products caused an alarming environmental concern and associated public health risks. The present study aims to assess the co-selection of antibiotic resistance and heavy metal tolerance by bacteria isolated from hospital effluents. These isolates were also tested for hemolytic activity, pH-tolerance, thermal inactivation, auto- aggregation, cell-surface hydrophobicity and interaction with other bacteria. The study reports the prevalence of antibiotic-resistant and heavy metal tolerant bacteria in clinical effluents and water samples. Most of these isolates were resistant to vancomycin, clindamycin, ampicillin, rifampicin, penicillin-G, methicillin and cefdinir, and evidenced the production of extended-spectrum β-lactamase enzyme. Toxic metals such as cadmium, copper, iron, lead and zinc also exert a selection pressure towards antibiotic resistance. Pseudomonas aeruginosa strain GCC_19W3, Bacillus sp. strain GCC_19S2 and Achromobacter spanius strain GCC_SB1 showed β-hemolysis, evidenced by the complete breakdown of the red blood cells.
    [Show full text]
  • CRISPR-Cas Systems Restrict Horizontal Gene Transfer In
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.19.304717; this version posted September 19, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 CRISPR-Cas systems restrict horizontal gene transfer in 2 Pseudomonas aeruginosa 3 Running title: CRISPR-Cas systems in Pseudomonas aeruginosa 4 5 Authors: Rachel M. Wheatley1,* and R. Craig MacLean1 6 7 Affiliations: Department of Zoology, University of Oxford, Oxford OX1 3PS, UK 8 9 Contact details: [email protected] 10 11 Competing interests 12 This project was supported by Wellcome Trust Grant 106918/Z/15/Z held by RCM. The authors declare 13 they have no conflict of interest. 14 15 16 17 18 19 20 21 22 23 24 25 26 27 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.09.19.304717; this version posted September 19, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 28 Abstract 29 CRISPR-Cas systems provide bacteria and archaea with an adaptive immune system that targets foreign 30 DNA. However, the xenogenic nature of immunity provided by CRISPR-Cas raises the possibility that 31 these systems may constrain horizontal gene transfer. Here we test this hypothesis in the opportunistic 32 pathogen Pseudomonas aeruginosa, which has emerged an important model system for understanding 33 CRISPR-Cas function. Across the diversity of P. aeruginosa, active CRISPR-Cas systems are 34 associated with smaller genomes and a reduced GC content, suggesting that CRISPR-Cas inhibits the 35 acquisition of foreign DNA.
    [Show full text]
  • CRISPR Interference (Crispri) for Gene Regulation and Succinate Production in Cyanobacterium S
    Huang et al. Microb Cell Fact (2016) 15:196 DOI 10.1186/s12934-016-0595-3 Microbial Cell Factories RESEARCH Open Access CRISPR interference (CRISPRi) for gene regulation and succinate production in cyanobacterium S. elongatus PCC 7942 Chun‑Hung Huang, Claire R. Shen, Hung Li, Li‑Yu Sung, Meng‑Ying Wu and Yu‑Chen Hu* Abstract Background: Cyanobacterium Synechococcus elongatus PCC 7942 holds promise for biochemical conversion, but gene deletion in PCC 7942 is time-consuming and may be lethal to cells. CRISPR interference (CRISPRi) is an emerging technology that exploits the catalytically inactive Cas9 (dCas9) and single guide RNA (sgRNA) to repress sequence- specific genes without the need of gene knockout, and is repurposed to rewire metabolic networks in various pro‑ caryotic cells. Results: To employ CRISPRi for the manipulation of gene network in PCC 7942, we integrated the cassettes express‑ ing enhanced yellow fluorescent protein (EYFP), dCas9 and sgRNA targeting different regions on eyfp into the PCC 7942 chromosome. Co-expression of dCas9 and sgRNA conferred effective and stable suppression of EYFP produc‑ tion at efficiencies exceeding 99%, without impairing cell growth. We next integrated the dCas9 and sgRNA targeting endogenous genes essential for glycogen accumulation (glgc) and succinate conversion to fumarate (sdhA and sdhB). Transcription levels of glgc, sdhA and sdhB were effectively suppressed with efficiencies depending on the sgRNA binding site. Targeted suppression of glgc reduced the expression to 6.2%, attenuated the glycogen accumulation to 4.8% and significantly enhanced the succinate titer. Targeting sdhA or sdhB also effectively downregulated the gene expression and enhanced the succinate titer 12.5-fold to 0.58–0.63 mg/L.
    [Show full text]
  • RNA Interference in the Age of CRISPR: Will CRISPR Interfere with Rnai?
    International Journal of Molecular Sciences Review RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi? Unnikrishnan Unniyampurath 1, Rajendra Pilankatta 2 and Manoj N. Krishnan 1,* 1 Program on Emerging Infectious Diseases, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore; [email protected] 2 Department of Biochemistry and Molecular Biology, School of Biological Sciences, Central University of Kerala, Nileshwar 671328, India; [email protected] * Correspondence: [email protected]; Tel.: +65-6516-2666 Academic Editor: Michael Ladomery Received: 2 November 2015; Accepted: 15 February 2016; Published: 26 February 2016 Abstract: The recent emergence of multiple technologies for modifying gene structure has revolutionized mammalian biomedical research and enhanced the promises of gene therapy. Over the past decade, RNA interference (RNAi) based technologies widely dominated various research applications involving experimental modulation of gene expression at the post-transcriptional level. Recently, a new gene editing technology, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and the CRISPR-associated protein 9 (Cas9) (CRISPR/Cas9) system, has received unprecedented acceptance in the scientific community for a variety of genetic applications. Unlike RNAi, the CRISPR/Cas9 system is bestowed with the ability to introduce heritable precision insertions and deletions in the eukaryotic genome. The combination of popularity and superior capabilities of CRISPR/Cas9 system raises the possibility that this technology may occupy the roles currently served by RNAi and may even make RNAi obsolete. We performed a comparative analysis of the technical aspects and applications of the CRISPR/Cas9 system and RNAi in mammalian systems, with the purpose of charting out a predictive picture on whether the CRISPR/Cas9 system will eclipse the existence and future of RNAi.
    [Show full text]
  • Development of CRISPR Interference (Crispri) Platform for Metabolic Engineering of Leuconostoc Citreum and Its Application for Engineering Riboflavin Biosynthesis
    International Journal of Molecular Sciences Article Development of CRISPR Interference (CRISPRi) Platform for Metabolic Engineering of Leuconostoc citreum and Its Application for Engineering Riboflavin Biosynthesis Jaewoo Son 1, Seung Hoon Jang 1, Ji Won Cha 1 and Ki Jun Jeong 1,2,* 1 Department of Chemical and Biomolecular Engineering, BK21 Plus program, KAIST, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Korea; [email protected] (J.S.); [email protected] (S.H.J.); [email protected] (J.W.C.) 2 Institute for The BioCentury, KAIST, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Korea * Correspondence: [email protected]; Tel.: +82-42-350-3934 Received: 1 July 2020; Accepted: 3 August 2020; Published: 5 August 2020 Abstract: Leuconostoc citreum, a hetero-fermentative type of lactic acid bacteria, is a crucial probiotic candidate because of its ability to promote human health. However, inefficient gene manipulation tools limit its utilization in bioindustries. We report, for the first time, the development of a CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) interference (CRISPRi) system for engineering L. citreum. For reliable expression, the expression system of synthetic single guide RNA (sgRNA) and the deactivated Cas9 of Streptococcus pyogenes (SpdCas9) were constructed in a bicistronic design (BCD) platform using a high-copy-number plasmid. The expression of SpdCas9 and sgRNA was optimized by examining the combination of two synthetic promoters and Shine–Dalgarno sequences; the strong expression of sgRNA and the weak expression of SpdCas9 exhibited the most significant downregulation (20-fold decrease) of the target gene (sfGFP), without cell growth retardation caused by SpdCas9 overexpression.
    [Show full text]
  • Challenges, New Technologies and Their Use in Plants
    International Journal of Molecular Sciences Review Chromatin Manipulation and Editing: Challenges, New Technologies and Their Use in Plants Kateryna Fal 1,† , Denisa Tomkova 2,†, Gilles Vachon 1 , Marie-Edith Chabouté 2, Alexandre Berr 2,* and Cristel C. Carles 1,* 1 Laboratoire de Physiologie Cellulaire et Végétale, Université Grenoble Alpes, CNRS, CEA, INRAE, IRIG-LPCV, 38000 Grenoble, France; [email protected] (K.F.); [email protected] (G.V.) 2 Institut de Biologie Moléculaire des Plantes du CNRS, Université de Strasbourg, 12 rue du Général Zimmer, 67084 Strasbourg CEDEX, France; [email protected] (D.T.); [email protected] (M.-E.C.) * Correspondence: [email protected] (A.B.); [email protected] (C.C.C.) † These authors contributed equally to this work. Abstract: An ongoing challenge in functional epigenomics is to develop tools for precise manipulation of epigenetic marks. These tools would allow moving from correlation-based to causal-based findings, a necessary step to reach conclusions on mechanistic principles. In this review, we describe and discuss the advantages and limits of tools and technologies developed to impact epigenetic marks, and which could be employed to study their direct effect on nuclear and chromatin structure, on transcription, and their further genuine role in plant cell fate and development. On one hand, epigenome-wide approaches include drug inhibitors for chromatin modifiers or readers, nanobodies against histone marks or lines expressing modified histones or mutant chromatin effectors. On the other hand, locus-specific approaches consist in targeting precise regions on the chromatin, with engineered proteins able to modify epigenetic marks.
    [Show full text]
  • International Journal of Systematic and Evolutionary Microbiology (2016), 66, 5575–5599 DOI 10.1099/Ijsem.0.001485
    International Journal of Systematic and Evolutionary Microbiology (2016), 66, 5575–5599 DOI 10.1099/ijsem.0.001485 Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Mobolaji Adeolu,† Seema Alnajar,† Sohail Naushad and Radhey S. Gupta Correspondence Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Radhey S. Gupta L8N 3Z5, Canada [email protected] Understanding of the phylogeny and interrelationships of the genera within the order ‘Enterobacteriales’ has proven difficult using the 16S rRNA gene and other single-gene or limited multi-gene approaches. In this work, we have completed comprehensive comparative genomic analyses of the members of the order ‘Enterobacteriales’ which includes phylogenetic reconstructions based on 1548 core proteins, 53 ribosomal proteins and four multilocus sequence analysis proteins, as well as examining the overall genome similarity amongst the members of this order. The results of these analyses all support the existence of seven distinct monophyletic groups of genera within the order ‘Enterobacteriales’. In parallel, our analyses of protein sequences from the ‘Enterobacteriales’ genomes have identified numerous molecular characteristics in the forms of conserved signature insertions/deletions, which are specifically shared by the members of the identified clades and independently support their monophyly and distinctness. Many of these groupings, either in part or in whole, have been recognized in previous evolutionary studies, but have not been consistently resolved as monophyletic entities in 16S rRNA gene trees. The work presented here represents the first comprehensive, genome- scale taxonomic analysis of the entirety of the order ‘Enterobacteriales’.
    [Show full text]
  • Cedecea Davisae Gen
    INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, July 1981, p. 317-326 Vol. 31, No. 3 0020-7713/81/030317-10$02.00/0 Cedecea davisae gen. nov., sp. nov. and Cedecea lapagei sp. nov., New Entero bacteriaceae from Clinical Specimens PATRICK A. D. GRIMONT,’ FRANCINE GRIMONT,’ J. J. FARMER 111,2 AND MARY A. ASBURY’ Service des Enterobacteries, INSERM Unit 199, Institut Pasteur, F- 75724 Paris Cedex 15, France,’ and Enteric Section, Centers for Disease Control, Atlanta, Georgia 303332 We propose the name Cedecea gen. nov. for a group of organisms in the Enterobacteriaceae that were isolated from clinical sources in North America (the clinical significance of these organisms is unknown). This name was coined by two of us (P.A.D.G. and F.G.) from the letters CDC, the abbreviation for the Centers for Disease Control, where the organisms were originally discovered. Phenotypically, Cedecea resembles no other group of Entero bacteriaceae; the members of this genus are lipase positive, resistant to colistin and cephalothin, and negative for deoxyribonuclease, gelatin liquefaction, and utilization of L- arabinose and L-rhamnose. Deoxyribonucleic acid relatedness studies showed that Cedecea strains were 32 to 100% related to each other and less than 23% related to other members of the Enterobacteriaceae. We found five deoxyribo- nucleic acid hybridization groups among 17 Cedecea strains, but three of these groups contained only 1 strain (strains 001,002, and 012). Two deoxyribonucleic acid hybridization groups were named. Cedecea davisae sp. nov. (nine strains), the type species of the genus, fermented sucrose and D-XylOSe and was positive in the ornithine decarboxylase and ascorbate tests.
    [Show full text]
  • An Inducible CRISPR Interference Library for Genetic Interrogation Of
    ARTICLE https://doi.org/10.1038/s42003-020-01452-9 OPEN An inducible CRISPR interference library for genetic interrogation of Saccharomyces cerevisiae biology ✉ Amir Momen-Roknabadi 1,2,3,4, Panos Oikonomou 1,2,3,4, Maxwell Zegans 2 & Saeed Tavazoie 1,2,3 1234567890():,; Genome-scale CRISPR interference (CRISPRi) is widely utilized to study cellular processes in a variety of organisms. Despite the dominance of Saccharomyces cerevisiae as a model eukaryote, an inducible genome-wide CRISPRi library in yeast has not yet been presented. Here, we present a genome-wide, inducible CRISPRi library, based on spacer design rules optimized for S. cerevisiae. We have validated this library for genome-wide interrogation of gene function across a variety of applications, including accurate discovery of haploinsuffi- cient genes and identification of enzymatic and regulatory genes involved in adenine and arginine biosynthesis. The comprehensive nature of the library also revealed refined spacer design parameters for transcriptional repression, including location, nucleosome occupancy and nucleotide features. CRISPRi screens using this library can identify genes and pathways with high precision and a low false discovery rate across a variety of experimental conditions, enabling rapid and reliable assessment of genetic function and interactions in S. cerevisiae. 1 Department of Biological Sciences, Columbia University, New York City, NY, USA. 2 Department of Systems Biology, Columbia University, New York City, NY, USA. 3 Department of Biochemistry and Molecular
    [Show full text]
  • CRISPR-Cas Systems and RNA-Guided Interference Rodolphe Barrangou∗
    Advanced Review CRISPR-Cas systems and RNA-guided interference Rodolphe Barrangou∗ Clustered regularly interspaced short palindromic repeats (CRISPR) together with associated sequences (cas) form the CRISPR-Cas system, which provides adaptive immunity against viruses and plasmids in bacteria and archaea. Immunity is built through acquisition of short stretches of invasive nucleic acids into CRISPR loci as ‘spacers’. These immune markers are transcribed and processed into small noncoding interfering CRISPR RNAs (crRNAs) that guide Cas proteins toward target nucleic acids for specific cleavage of homologous sequences. Mechanistically, CRISPR-Cas systems function in three distinct stages, namely: (1) adaptation, where new spacers are acquired from invasive elements for immunization; (2) crRNA biogenesis, where CRISPR loci are transcribed and processed into small interfering crRNAs; and (3) interference, where crRNAs guide the Cas machinery to specifically cleave homologous invasive nucleic acids. A number of studies have shown that CRISPR-mediated immunity can readily increase the breadth and depth of virus resistance in bacteria and archaea. CRISPR interference can also target plasmid sequences and provide a barrier against the uptake of undesirable mobile genetic elements. These inheritable hypervariable loci provide phylogenetic information that can be insightful for typing purposes, epidemiological studies, and ecological surveys of natural habitats and environmental samples. More recently, the ability to reprogram CRISPR-directed endonuclease activity using customizable small noncoding interfering RNAs has set the stage for novel genome editing and engineering avenues. This review highlights recent studies that revealed the molecular basis of CRISPR-mediated immunity, and discusses applications of crRNA-guided interference. 2013 John Wiley & Sons, Ltd. How to cite this article: WIREs RNA 2013, 4:267–278.
    [Show full text]